Infection Surveillance Solutions Market
完整報告名稱與涵蓋範圍
Infection Surveillance Solutions Market Size, Share & Trends Analysis Report By Product & Services (Software (On-premise Software, Web-based Software), Up to 50 hp (Product Support & Maintenance Services, Implementation Services, Training & Consulting services), By End User, By Region, And By Segment Forecasts, 2023-2031
報告摘要
In 2022, the Infection Surveillance Solutions Market worldwide was assessed at USD 544.93 Mn. Analysts project it will advance to USD 1581.37 Mn by 2031, at a CAGR of 12.7% spanning 2023 to 2031.
Infection Surveillance Solutions encompasses The term "infection surveillance solutions" involves challenges.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Infection Surveillance Solutions Market Snapshot
Chapter 4. Global Infection Surveillance Solutions Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product & Services Estimates & Trend Analysis
5.1. By Product & Services & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Product & Services:
5.2.1. Software
5.2.1.1. On-premise Software
5.2.1.2. Web-based Software
5.2.2. Services
5.2.2.1. Product Support & Maintenance Services
5.2.2.2. Implementation Services
5.2.2.3. Training & Consulting services
Chapter 6. Market Segmentation 2: By End User Estimates & Trend Analysis
6.1. By Product & Services & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End User:
6.2.1. Hospitals
6.2.1.1. Large Hospitals
6.2.1.2. Medium Sized Hospitals
6.2.1.3. Small Hospitals
6.2.2. Long-term Care Facilities
6.2.2.1. Nursing Homes
6.2.2.2. Skilled Nursing Facilities
6.2.2.3. Assisted- Living Facilities
6.2.3. Other End Users
Chapter 7. Infection Surveillance Solutions Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By Product & Services, 2023-2031
7.1.2. North America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.1.3. North America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.1.3.1. U.S.
7.1.4. Canada
7.2. Europe
7.2.1. Europe Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, 2023-2031
7.2.2. Europe Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.2.3. Europe Infection Surveillance Solutions Market revenue (US$ Million) by country, 2023-2031
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, 2023-2031
7.3.2. Asia Pacific Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.3.3. Asia Pacific Infection Surveillance Solutions Market revenue (US$ Million) by country, 2023-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, 2023-2031
7.4.2. Latin America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.4.3. Latin America Infection Surveillance Solutions Market revenue (US$ Million) By country, (US$ Million) 2023-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, (US$ Million)
7.5.2. Middle East & Africa Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.5.3. Middle East & Africa Infection Surveillance Solutions Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Becton, Dickinson and Company (US)
8.2.2. Premier, Inc. (US)
8.2.3. Wolters Kluwer N.V. (Netherlands)
8.2.4. Cerner Corporation (US)
8.2.5. Baxter International Inc. (US)
8.2.6. GOJO Industries, Inc. (US)
8.2.7. Clinisys (US)
8.2.8. Deb Group Ltd. (UK)
8.2.9. BioVigil Healthcare Systems (US)
8.2.10. RLDatix (UK)
8.2.11. Merative (US)
8.2.12. Vecna Technologies, Inc. (US)
8.2.13. VigiLanz Corporation (US)
8.2.14. Ecolab (US)
8.2.15. Harris Healthcare (US)
8.2.16. PeraHealth (US)
8.2.17. Medexter Healthcare (Austria)
8.2.18. CenTrak, Inc. (US)
8.2.19. BioMerieux SA (France)
8.2.20. CKM Healthcare (Canada)
8.2.21. Asolva Inc. (US)
8.2.22. PointClickCare (Canada)
8.2.23. STANLEY Healthcare (US)
8.2.24. Vitalacy Inc. (US)
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們